New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target is a research paper published in BioEssays (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Institute of Musculoskeletal Health and Arthritis
Grant: PJT‐186092
Muscular Dystrophy Canada
Grant: 855145
Muscular Dystrophy Association
Grant: 1192211
U.S. Army Medical Research Acquisition Activity
Grant: PR231850
National Institutes of Health
Grant: R01NS12048501
NINDS NIH HHS
Grant: R01 NS120485
NINDS NIH HHS
Grant: R01 NS135254
Institute of Musculoskeletal Health and Arthritis
Grant: PJT-186092
MeSH Terms
Keywords